Literature DB >> 24781210

The genetic landscape of infantile spasms.

Jacques L Michaud1, Mathieu Lachance2, Fadi F Hamdan2, Lionel Carmant1, Anne Lortie1, Paola Diadori1, Philippe Major1, Inge A Meijer2, Emmanuelle Lemyre3, Patrick Cossette4, Heather C Mefford5, Guy A Rouleau6, Elsa Rossignol7.   

Abstract

Infantile spasms (IS) is an early-onset epileptic encephalopathy of unknown etiology in ∼40% of patients. We hypothesized that unexplained IS cases represent a large collection of rare single-gene disorders. We investigated 44 children with unexplained IS using comparative genomic hybridisation arrays (aCGH) (n = 44) followed by targeted sequencing of 35 known epilepsy genes (n = 8) or whole-exome sequencing (WES) of familial trios (n = 18) to search for rare inherited or de novo mutations. aCGH analysis revealed de novo variants in 7% of patients (n = 3/44), including a distal 16p11.2 duplication, a 15q11.1q13.1 tetrasomy and a 2q21.3-q22.2 deletion. Furthermore, it identified a pathogenic maternally inherited Xp11.2 duplication. Targeted sequencing was informative for ARX (n = 1/14) and STXBP1 (n = 1/8). In contrast, sequencing of a panel of 35 known epileptic encephalopathy genes (n = 8) did not identify further mutations. Finally, WES (n = 18) was very informative, with an excess of de novo mutations identified in genes predicted to be involved in neurodevelopmental processes and/or known to be intolerant to functional variations. Several pathogenic mutations were identified, including de novo mutations in STXBP1, CASK and ALG13, as well as recessive mutations in PNPO and ADSL, together explaining 28% of cases (5/18). In addition, WES identified 1-3 de novo variants in 64% of remaining probands, pointing to several interesting candidate genes. Our results indicate that IS are genetically heterogeneous with a major contribution of de novo mutations and that WES is significantly superior to targeted re-sequencing in identifying detrimental genetic variants involved in IS.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2014        PMID: 24781210     DOI: 10.1093/hmg/ddu199

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  67 in total

1.  Genomic analysis identifies candidate pathogenic variants in 9 of 18 patients with unexplained West syndrome.

Authors:  Naomi Hino-Fukuyo; Atsuo Kikuchi; Natsuko Arai-Ichinoi; Tetsuya Niihori; Ryo Sato; Tasuku Suzuki; Hiroki Kudo; Yuko Sato; Tojo Nakayama; Yosuke Kakisaka; Yuki Kubota; Tomoko Kobayashi; Ryo Funayama; Keiko Nakayama; Mitsugu Uematsu; Yoko Aoki; Kazuhiro Haginoya; Shigeo Kure
Journal:  Hum Genet       Date:  2015-04-16       Impact factor: 4.132

2.  Ex Utero Electroporation and Organotypic Slice Cultures of Embryonic Mouse Brains for Live-Imaging of Migrating GABAergic Interneurons.

Authors:  Lara Eid; Mathieu Lachance; Gilles Hickson; Elsa Rossignol
Journal:  J Vis Exp       Date:  2018-04-20       Impact factor: 1.355

Review 3.  The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.

Authors:  Davide Mei; Elena Parrini; Carla Marini; Renzo Guerrini
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

Review 4.  Neurological aspects of human glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Annu Rev Neurosci       Date:  2015-04-02       Impact factor: 12.449

5.  Knockin' Out the Spasms.

Authors:  Libor Velíšek
Journal:  Epilepsy Curr       Date:  2017 May-Jun       Impact factor: 7.500

6.  Diagnostic yield of genetic tests in epilepsy: A meta-analysis and cost-effectiveness study.

Authors:  Iván Sánchez Fernández; Tobias Loddenkemper; Marina Gaínza-Lein; Beth Rosen Sheidley; Annapurna Poduri
Journal:  Neurology       Date:  2019-01-04       Impact factor: 9.910

7.  Biallelic Variants in CNPY3, Encoding an Endoplasmic Reticulum Chaperone, Cause Early-Onset Epileptic Encephalopathy.

Authors:  Hiroki Mutoh; Mitsuhiro Kato; Tenpei Akita; Takuma Shibata; Hiroyuki Wakamoto; Hiroko Ikeda; Hiroki Kitaura; Kazushi Aoto; Mitsuko Nakashima; Tianying Wang; Chihiro Ohba; Satoko Miyatake; Noriko Miyake; Akiyoshi Kakita; Kensuke Miyake; Atsuo Fukuda; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Am J Hum Genet       Date:  2018-01-27       Impact factor: 11.025

8.  Normal Cerebrospinal Fluid Pyridoxal 5'-Phosphate Level in a PNPO-Deficient Patient with Neonatal-Onset Epileptic Encephalopathy.

Authors:  Alina Levtova; Stephane Camuzeaux; Anne-Marie Laberge; Pierre Allard; Catherine Brunel-Guitton; Paola Diadori; Elsa Rossignol; Keith Hyland; Peter T Clayton; Philippa B Mills; Grant A Mitchell
Journal:  JIMD Rep       Date:  2015-03-12

9.  Commentary: 2016 Clinical Epilepsia Prize.

Authors:  David T Miller
Journal:  Epilepsia       Date:  2016-08-14       Impact factor: 5.864

Review 10.  WONOEP appraisal: new genetic approaches to study epilepsy.

Authors:  Elsa Rossignol; Katja Kobow; Michele Simonato; Jeffrey A Loeb; Thierry Grisar; Krista L Gilby; Jonathan Vinet; Shilpa D Kadam; Albert J Becker
Journal:  Epilepsia       Date:  2014-06-25       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.